{"count": 5, "results": [{"_id": "33381033", "pmid": 33381033, "pmcid": "PMC7768040", "title": "The Efficacy of Beta-Blockers in Patients With Long QT Syndrome 1-3 According to Individuals' Gender, Age, and QTc Intervals: A Network Meta-analysis", "journal": "Front Pharmacol", "authors": ["Han L", "Liu F", "Li Q", "Qing T", "Zhai Z", "Xia Z", "Li J"], "date": "2020-12-14T00:00:00Z", "doi": "10.3389/fphar.2020.579525", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "", "meta_pages": "579525", "score": 50247.242, "text_hl": "The most common BBs include @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@, @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@, and @CHEMICAL_Nadolol @CHEMICAL_MESH:D009248 @@@nadolol@@@, all of which are efficient at reducing the risk of cardiac events [@DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@CEs@@@, e.g., @DISEASE_Syncope @DISEASE_MESH:D013575 @@@syncope@@@, @DISEASE_Heart_Arrest @DISEASE_MESH:D006323 @@@aborted cardiac arrest@@@ (@DISEASE_Heart_Arrest @DISEASE_MESH:D006323 @@@ACA@@@), and @<m>DISEASE_Death_Sudden_Cardiac</m> @DISEASE_MESH:D016757 @@@sudden cardiac death@@@ (@<m>DISEASE_Death_Sudden_Cardiac</m> @DISEASE_MESH:D016757 @@@SCD@@@)] in @DISEASE_Post_Acute_COVID_19_Syndrome @DISEASE_MESH:D000094024 @@@LQTS@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Han L, Liu F, Li Q, Qing T, Zhai Z, Xia Z, Li J. The Efficacy of Beta-Blockers in Patients With Long QT Syndrome 1-3 According to Individuals' Gender, Age, and QTc Intervals: A Network Meta-analysis Front Pharmacol. 2020;11():579525. PMID: 33381033", "BibTeX": "@article{33381033, title={The Efficacy of Beta-Blockers in Patients With Long QT Syndrome 1-3 According to Individuals' Gender, Age, and QTc Intervals: A Network Meta-analysis}, author={Han L and Liu F and Li Q and Qing T and Zhai Z and Xia Z and Li J}, journal={Front Pharmacol}, volume={11}, pages={579525}}"}}, {"_id": "9594263", "pmid": 9594263, "title": "Secondary prevention of cardiac events following myocardial infarction: effects of atenolol and enalapril. Beijing Collaborative Study Group.", "journal": "Chin Med J (Engl)", "authors": ["Wu N", "Fan Z"], "date": "1997-08-01T00:00:00Z", "meta_date_publication": "1997 Aug", "meta_volume": "110", "meta_issue": "8", "meta_pages": "602-6", "score": 50062.516, "text_hl": "Comparing with group C, the rate of @<m>DISEASE_Death_Sudden_Cardiac</m> @DISEASE_MESH:D016757 @@@SCD@@@ decreased significantly by 68% in group A after @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ treatment for 28 months. ", "citations": {"NLM": "Wu N, Fan Z. Secondary prevention of cardiac events following myocardial infarction: effects of atenolol and enalapril. Beijing Collaborative Study Group. Chin Med J (Engl). 1997 Aug;110(8):602-6. PMID: 9594263", "BibTeX": "@article{9594263, title={Secondary prevention of cardiac events following myocardial infarction: effects of atenolol and enalapril. Beijing Collaborative Study Group.}, author={Wu N and Fan Z}, journal={Chin Med J (Engl)}, volume={110}, number={8}, pages={602-6}}"}}, {"_id": "19687165", "pmid": 19687165, "title": "QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study.", "journal": "Eur Heart J", "authors": ["Morin DP", "Oikarinen L", "Viitasalo M", "Toivonen L", "Nieminen MS", "Kjeldsen SE", "Dahlöf B", "John M", "Devereux RB", "Okin PM"], "date": "2009-12-01T00:00:00Z", "doi": "10.1093/eurheartj/ehp321", "meta_date_publication": "2009 Dec", "meta_volume": "30", "meta_issue": "23", "meta_pages": "2908-14", "score": 50053.27, "text_hl": "METHODS AND RESULTS: Over 4.8 +/- 0.9 years follow-up of 9193 @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with electrocardiographic evidence of LVH who were treated with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@- or @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@-based regimens, 178 @SPECIES_9606 @@@patients@@@ (1.9%) suffered @<m>DISEASE_Death_Sudden_Cardiac</m> @DISEASE_MESH:D016757 @@@SCD@@@. ", "citations": {"NLM": "Morin DP, Oikarinen L, Viitasalo M, Toivonen L, Nieminen MS, Kjeldsen SE, Dahlöf B, John M, Devereux RB, Okin PM. QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study. Eur Heart J. 2009 Dec;30(23):2908-14. PMID: 19687165", "BibTeX": "@article{19687165, title={QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study.}, author={Morin DP and Oikarinen L and Viitasalo M and Toivonen L and Nieminen MS and Kjeldsen SE and Dahlöf B and John M and Devereux RB and Okin PM}, journal={Eur Heart J}, volume={30}, number={23}, pages={2908-14}}"}}, {"_id": "22079554", "pmid": 22079554, "title": "Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study.", "journal": "Heart Rhythm", "authors": ["Okin PM", "Kjeldsen SE", "Julius S", "Dahlöf B", "Devereux RB"], "date": "2012-04-01T00:00:00Z", "doi": "10.1016/j.hrthm.2011.11.008", "meta_date_publication": "2012 Apr", "meta_volume": "9", "meta_issue": "4", "meta_pages": "531-7", "score": 50052.285, "text_hl": "OBJECTIVES: To determine whether black @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ have a higher @<m>DISEASE_Death_Sudden_Cardiac</m> @DISEASE_MESH:D016757 @@@SCD@@@ incidence. METHODS: The incidence of @<m>DISEASE_Death_Sudden_Cardiac</m> @DISEASE_MESH:D016757 @@@SCD@@@ was examined in 533 black and 8660 nonblack @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with electrocardiographic @DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@left ventricular hypertrophy@@@ randomly assigned to @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@- or @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@-based treatment. ", "citations": {"NLM": "Okin PM, Kjeldsen SE, Julius S, Dahlöf B, Devereux RB. Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study. Heart Rhythm. 2012 Apr;9(4):531-7. PMID: 22079554", "BibTeX": "@article{22079554, title={Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study.}, author={Okin PM and Kjeldsen SE and Julius S and Dahlöf B and Devereux RB}, journal={Heart Rhythm}, volume={9}, number={4}, pages={531-7}}"}}, {"_id": "26776587", "pmid": 26776587, "title": "Effect of atenolol on heart rate, arrhythmias, blood pressure, and dynamic left ventricular outflow tract obstruction in cats with subclinical hypertrophic cardiomyopathy.", "journal": "J Vet Cardiol", "authors": ["Jackson BL", "Adin DB", "Lehmkuhl LB"], "date": "2015-12-01T00:00:00Z", "doi": "10.1016/j.jvc.2015.03.002", "meta_date_publication": "2015 Dec", "meta_volume": "17 Suppl 1", "meta_issue": "", "meta_pages": "S296-305", "score": 50050.97, "text_hl": "Further studies are needed to determine if @<m>DISEASE_Death_Sudden_Cardiac</m> @DISEASE_MESH:D016757 @@@sudden cardiac death@@@ or long-term outcome is influenced by @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ administration.", "citations": {"NLM": "Jackson BL, Adin DB, Lehmkuhl LB. Effect of atenolol on heart rate, arrhythmias, blood pressure, and dynamic left ventricular outflow tract obstruction in cats with subclinical hypertrophic cardiomyopathy. J Vet Cardiol. 2015 Dec;17 Suppl 1():S296-305. PMID: 26776587", "BibTeX": "@article{26776587, title={Effect of atenolol on heart rate, arrhythmias, blood pressure, and dynamic left ventricular outflow tract obstruction in cats with subclinical hypertrophic cardiomyopathy.}, author={Jackson BL and Adin DB and Lehmkuhl LB}, journal={J Vet Cardiol}, volume={17 Suppl 1}, pages={S296-305}}"}}]}